The effect of the alterations on radiosensitivity caused by RAC1 inhibition is markedly increased in radiosensitivity of pancreatic cancer cells, as demonstrated by caspase-3 activation (32). The gene discussed is CASP3; the disease is pancreatic neoplasm.